Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 375

1.

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.

Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko K, Fujisawa T, Takahashi M, Kadoya T, Matsunami N, Yamamoto Y, Ohno S, Takano T, Morita S, Tanaka-Mizuno S, Toi M.

Breast Cancer Res Treat. 2020 Apr;180(3):715-724. doi: 10.1007/s10549-020-05590-w. Epub 2020 Mar 13.

2.

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

Yamashiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Kuroi K, Takano T, Yasuno S, Morita S, Ohno S, Toi M; JBCRG-C01 Collaborative Group.

Breast Cancer. 2020 Feb 14. doi: 10.1007/s12282-020-01057-4. [Epub ahead of print]

PMID:
32060785
3.

Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab.

Hisamatsu Y, Morinaga R, Watanabe E, Ohtani S, Shirao K.

Am J Case Rep. 2020 Feb 4;21:e920809. doi: 10.12659/AJCR.920809.

4.

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer.

Masuda N, Ohtani S, Takano T, Inoue K, Suzuki E, Nakamura R, Bando H, Ito Y, Ishida K, Yamanaka T, Kuroi K, Yasojima H, Kasai H, Takasuka T, Sakurai T, Kataoka TR, Morita S, Ohno S, Toi M.

Breast Cancer Res Treat. 2020 Feb;180(1):135-146. doi: 10.1007/s10549-020-05524-6. Epub 2020 Jan 17.

5.

Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study.

Ueno T, Masuda N, Sato N, Ohtani S, Yamamura J, Matsunami N, Kashiwaba M, Takano T, Takahashi M, Kaneko K, Ohno S, Morita S, Toi M.

Jpn J Clin Oncol. 2020 Jan 24;50(1):3-11. doi: 10.1093/jjco/hyz119.

6.

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.

Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S.

Breast Cancer. 2019 Dec 6. doi: 10.1007/s12282-019-01029-3. [Epub ahead of print]

PMID:
31811519
7.

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.

Iwasa T, Tsurutani J, Watanabe S, Kato R, Mizuno Y, Kojima Y, Takashima T, Matsunami N, Morimoto T, Yamamura J, Ohtani S, Tanabe Y, Yoshinami T, Takano T, Komoike Y, Nakagawa K.

BMC Cancer. 2019 Oct 16;19(1):962. doi: 10.1186/s12885-019-6200-5.

8.

Immune correlates of the differing pathological and therapeutic effects of neoadjuvant chemotherapy in breast cancer.

Kim R, Kawai A, Wakisaka M, Sawada S, Shimoyama M, Yasuda N, Hidaka M, Morita Y, Ohtani S, Arihiro K.

Eur J Surg Oncol. 2020 Jan;46(1):77-84. doi: 10.1016/j.ejso.2019.09.146. Epub 2019 Sep 18.

PMID:
31563296
9.

Cephalometric analysis of the pharyngeal airway space after maxillary advancement surgery.

Aoki J, Shinozuka K, Yamagata K, Nakamura R, Sato T, Ohtani S, Ogisawa S, Yanagawa K, Tonogi M.

J Oral Sci. 2019 Nov 27;61(4):529-533. doi: 10.2334/josnusd.18-0422. Epub 2019 Sep 20.

10.

Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma.

Aihara M, Kuwayama Y, Miyata K, Ohtani S, Ideta R, Hashimoto Y, Sasaki N, Shirato S.

Jpn J Ophthalmol. 2019 Sep;63(5):402-409. doi: 10.1007/s10384-019-00682-7. Epub 2019 Jul 31.

PMID:
31367979
11.

The feasibility of contrast-enhanced spectral mammography immediately after contrast-enhanced CT.

Okada N, Tatsugami F, Sugai M, Okita I, Ito M, Ohtani S, Ichimura K, Urashima M, Awai K.

Radiol Phys Technol. 2019 Sep;12(3):277-282. doi: 10.1007/s12194-019-00518-6. Epub 2019 Jun 5.

PMID:
31165975
12.

Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer.

Iwata H, Masuda N, Kim SB, Inoue K, Rai Y, Fujita T, Chiu J, Ohtani S, Takahashi M, Miyaki T, Lu YS, Xu B, Yap YS, Bustam A, Yao B, Zhang B, Bryce R, Chan A.

Future Oncol. 2019 Jul;15(21):2489-2501. doi: 10.2217/fon-2019-0143. Epub 2019 May 29.

PMID:
31140297
13.

Global Analysis of Transcriptional Expression in Mice Exposed to Intermediate Frequency Magnetic Fields Utilized for Wireless Power Transfer Systems.

Ohtani S, Ushiyama A, Maeda M, Wada K, Suzuki Y, Hattori K, Kunugita N, Ishii K.

Int J Environ Res Public Health. 2019 May 25;16(10). pii: E1851. doi: 10.3390/ijerph16101851.

14.

Identification of geosmin biosynthetic gene in geosmin-producing colonial cyanobacteria Coelosphaerium sp. and isolation of geosmin non-producing Coelosphaerium sp. from brackish Lake Shinji in Japan.

Hayashi S, Ohtani S, Godo T, Nojiri Y, Saki Y, Esumi T, Kamiya H.

Harmful Algae. 2019 Apr;84:19-26. doi: 10.1016/j.hal.2019.01.010. Epub 2019 Mar 15.

PMID:
31128804
15.

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.

Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M.

J Glob Oncol. 2019 May;5:1-19. doi: 10.1200/JGO.18.00173.

16.

Deleted in colorectal cancer (netrin-1 receptor) antibodies and limbic encephalitis in a cat with hippocampal necrosis.

Hasegawa D, Ohnishi Y, Koyama E, Matsunaga S, Ohtani S, Nakanishi A, Shiga T, Chambers JK, Uchida K, Yokoi N, Fukata Y, Fukata M.

J Vet Intern Med. 2019 May;33(3):1440-1445. doi: 10.1111/jvim.15492. Epub 2019 Apr 3.

17.

Preparation of dentin standard samples for age estimation based on increased aspartic acid racemization rate by heating.

Minegishi S, Ohtani S, Noritake K, Funakoshi T, Ishii N, Utsuno H, Sakuma A, Saitoh H, Yamaguchi S, Marukawa E, Harada H, Uemura K, Sakurada K.

Leg Med (Tokyo). 2019 May;38:25-31. doi: 10.1016/j.legalmed.2019.03.005. Epub 2019 Mar 18.

PMID:
30925381
18.

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.

Fujiwara Y, Mukai H, Saeki T, Ro J, Lin YC, Nagai SE, Lee KS, Watanabe J, Ohtani S, Kim SB, Kuroi K, Tsugawa K, Tokuda Y, Iwata H, Park YH, Yang Y, Nambu Y.

Br J Cancer. 2019 Mar;120(5):475-480. doi: 10.1038/s41416-019-0391-z. Epub 2019 Feb 12.

19.

Clinical Predictive Factors for the Efficacy of Everolimus in Patients With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter Retrospective Cohort Study in Japan.

Kikawa Y, Kotake T, Kajiwara Y, Hashimoto K, Yamashiro H, Ohtani S, Takao S, Toi M.

Breast Cancer (Auckl). 2019 Jan 22;13:1178223418825135. doi: 10.1177/1178223418825135. eCollection 2019.

20.

A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients.

Kim R, Kawai A, Wakisaka M, Funaoka Y, Yasuda N, Hidaka M, Morita Y, Ohtani S, Ito M, Arihiro K.

Cancer Immunol Immunother. 2019 Apr;68(4):577-585. doi: 10.1007/s00262-019-02305-z. Epub 2019 Jan 23.

PMID:
30673828
21.

Reduction in adverse transfusion reactions with increased use of washed platelet concentrates in Japan-A retrospective multicenter study.

Ikebe E, Matsuoka S, Tanaka A, Yonemura Y, Fujii Y, Ohsaka A, Okazaki H, Kitazawa J, Ohtani S, Nakayama T, Momose SY, Miwa I, Taira R, Toyota K, Kino S, Kato H, Hamaguchi I.

Transfus Apher Sci. 2019 Apr;58(2):162-168. doi: 10.1016/j.transci.2018.12.021. Epub 2019 Jan 6.

PMID:
30670326
22.

Menthol-induced facilitation of cerebrocortical excitatory propagation induced by air puff stimulation of the nasal cavity in the rat: An optical imaging study.

Fujita S, Zama M, Kaneko K, Murayama S, Ohtani S, Usui M, Noma D, Tsuda H, Yamamoto K, Kobayashi M.

Neurosci Lett. 2019 Mar 23;696:87-92. doi: 10.1016/j.neulet.2018.12.018. Epub 2018 Dec 13.

PMID:
30553866
23.

Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.

Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M.

Int J Clin Oncol. 2019 Mar;24(3):274-287. doi: 10.1007/s10147-018-1353-9. Epub 2018 Dec 4.

24.

Relationship between the fluorescence intensity of rhodamine-labeled orexin A and the calcium responses in cortical neurons: An in vivo two-photon calcium imaging study.

Ohtani S, Fujita S, Hasegawa K, Tsuda H, Tonogi M, Kobayashi M.

J Pharmacol Sci. 2018 Sep;138(1):76-82. doi: 10.1016/j.jphs.2018.09.005. Epub 2018 Sep 22.

25.

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.

Iwata H, Masuda N, Yamamoto Y, Fujisawa T, Toyama T, Kashiwaba M, Ohtani S, Taira N, Sakai T, Hasegawa Y, Nakamura R, Akabane H, Shibahara Y, Sasano H, Yamaguchi T, Sakamaki K, Bailey H, Cherbavaz DB, Jakubowski DM, Sugiyama N, Chao C, Ohashi Y.

Breast Cancer Res Treat. 2019 Jan;173(1):123-133. doi: 10.1007/s10549-018-4964-y. Epub 2018 Sep 21.

26.

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study.

Yamashiro H, Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M.

Breast Cancer (Auckl). 2018 Jul 5;12:1178223418786243. doi: 10.1177/1178223418786243. eCollection 2018.

27.

Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.

Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M.

Breast Cancer Res Treat. 2018 Oct;171(3):675-683. doi: 10.1007/s10549-018-4873-0. Epub 2018 Jul 3.

PMID:
29971625
28.

The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.

Takabatake D, Kajiwara Y, Ohtani S, Itano Y, Yamamoto M, Kubo S, Ikeda M, Takahashi M, Hara F, Aogi K, Ohsumi S, Ogasawara Y, Nishiyama Y, Hikino H, Matsuoka K, Takahashi Y, Shien T, Taira N, Doihara H.

Breast Cancer. 2018 Nov;25(6):717-722. doi: 10.1007/s12282-018-0877-1. Epub 2018 Jun 11.

PMID:
29948957
29.

The scab-like sign: A CT finding indicative of haemoptysis in patients with chronic pulmonary aspergillosis?

Sato H, Okada F, Matsumoto S, Mori H, Kashiwagi J, Komatsu E, Maeda T, Nishida H, Daa T, Ohtani S, Umeki K, Ando M, Kadota J.

Eur Radiol. 2018 Oct;28(10):4053-4061. doi: 10.1007/s00330-018-5434-y. Epub 2018 May 3.

PMID:
29725831
30.

Chained nuclei and python pattern in skeletal muscle cells as histological markers for electrical injury.

Tanaka H, Okuda K, Ohtani S, Asari M, Horioka K, Isozaki S, Hayakawa A, Ogawa K, Hiroshi S, Shimizu K.

Leg Med (Tokyo). 2018 May;32:75-78. doi: 10.1016/j.legalmed.2017.11.001. Epub 2017 Nov 2.

PMID:
29579533
31.

Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial.

Masuda N, Toi M, Yamamoto N, Iwata H, Kuroi K, Bando H, Ohtani S, Takano T, Inoue K, Yanagita Y, Kasai H, Morita S, Sakurai T, Ohno S.

Breast Cancer. 2018 Jul;25(4):407-415. doi: 10.1007/s12282-018-0839-7. Epub 2018 Feb 14.

32.

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

Ohtani S, Nakayama T, Yoshinami T, Watanabe KI, Hara F, Sagara Y, Kawaguchi H, Higaki K, Matsunami N, Hasegawa Y, Takahashi M, Mizutani M, Morimoto T, Sato M, Itoh M, Morita S, Masuda N.

Breast Cancer. 2018 Jul;25(4):438-446. doi: 10.1007/s12282-018-0843-y. Epub 2018 Feb 12.

33.

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study.

Hattori M, Ishiguro H, Masuda N, Yoshimura A, Ohtani S, Yasojima H, Morita S, Ohno S, Iwata H.

Breast Cancer. 2018 Jan;25(1):126. doi: 10.1007/s12282-017-0815-7.

34.

Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study.

Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S.

Curr Med Res Opin. 2018 Jan;34(1):49-54. doi: 10.1080/03007995.2017.1400426. Epub 2017 Nov 21.

PMID:
29095648
35.

Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients.

Kim R, Kawai A, Wakisaka M, Funaoka Y, Ohtani S, Ito M, Kadoya T, Okada M.

Clin Transl Med. 2017 Sep 14;6(1):34. doi: 10.1186/s40169-017-0163-4.

36.

Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study.

Hattori M, Ishiguro H, Masuda N, Yoshimura A, Ohtani S, Yasojima H, Morita S, Ohno S, Iwata H.

Breast Cancer. 2018 Jan;25(1):108-117. doi: 10.1007/s12282-017-0798-4. Epub 2017 Aug 31. Erratum in: Breast Cancer. 2017 Nov 20;:.

37.

Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops.

Ohtani S, Shimizu K, Nejima R, Kagaya F, Aihara M, Iwasaki T, Shoji N, Miyata K.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3991-3996. doi: 10.1167/iovs.16-20853.

PMID:
28796877
38.

Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.

Yokoyama S, Tamaru S, Tamaki S, Nakanishi D, Mori A, Yamakawa T, Ao T, Sakata Y, Mizuno T, Iwamoto T, Watanabe K, Simomura M, Kawakami K, Konishi N, Kageyama S, Ohtani S, Yamada T, Ban S, Ooi K.

Clin Breast Cancer. 2018 Apr;18(2):e157-e165. doi: 10.1016/j.clbc.2017.05.013. Epub 2017 Jun 29.

PMID:
28735677
39.

A Flexible, Fused, Azomethine-Boron Complex: Thermochromic Luminescence and Thermosalient Behavior in Structural Transitions between Crystalline Polymorphs.

Ohtani S, Gon M, Tanaka K, Chujo Y.

Chemistry. 2017 Sep 4;23(49):11827-11833. doi: 10.1002/chem.201702309. Epub 2017 Jul 24.

PMID:
28628950
40.

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.

Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M.

N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645.

41.

Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.

Aoyama N, Nishinari M, Ohtani S, Kanai A, Noda C, Hirata M, Miyamoto A, Watanabe M, Minamino T, Izumi T, Ako J.

Heart Vessels. 2017 Sep;32(9):1099-1108. doi: 10.1007/s00380-017-0968-5. Epub 2017 Mar 29.

PMID:
28357515
42.

Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari).

Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita T, Yamamoto Y, Ohno S, Toi M.

Breast Cancer Res Treat. 2017 Jun;163(3):545-554. doi: 10.1007/s10549-017-4212-x. Epub 2017 Mar 23.

PMID:
28337663
43.

Geosmin-producing Species of Coelosphaerium (Synechococcales, Cyanobacteria) in Lake Shinji, Japan.

Godo T, Saki Y, Nojiri Y, Tsujitani M, Sugahara S, Hayashi S, Kamiya H, Ohtani S, Seike Y.

Sci Rep. 2017 Feb 14;7:41928. doi: 10.1038/srep41928.

44.

Exposure time-dependent thermal effects of radiofrequency electromagnetic field exposure on the whole body of rats.

Ohtani S, Ushiyama A, Maeda M, Hattori K, Kunugita N, Wang J, Ishii K.

J Toxicol Sci. 2016;41(5):655-66. doi: 10.2131/jts.41.655.

45.

14-3-3ζ-Mediated Stimulation of Oxidative Phosphorylation Exacerbates Oxidative Damage Under Hypothermic Oxygenated Conditions in Human Renal Tubular Cells (HK-2).

Fukai M, Kobayashi N, Ishikawa T, Wakayama K, Shimada S, Umemoto K, Ohtani S, Fujiyoshi M, Yamashita K, Shimamura T, Taketomi A.

Transplant Proc. 2016 May;48(4):1288-91. doi: 10.1016/j.transproceed.2015.09.066.

PMID:
27320606
46.

l-Lysine production independent of the oxidative pentose phosphate pathway by Corynebacterium glutamicum with the Streptococcus mutans gapN gene.

Takeno S, Hori K, Ohtani S, Mimura A, Mitsuhashi S, Ikeda M.

Metab Eng. 2016 Sep;37:1-10. doi: 10.1016/j.ymben.2016.03.007. Epub 2016 Mar 29.

PMID:
27044449
47.

Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial.

Sugiu K, Iwamoto T, Kelly CM, Watanabe N, Motoki T, Ito M, Ohtani S, Higaki K, Imada T, Yuasa T, Omori M, Sonobe H, Fujiwara T, Matsuoka J.

Acta Med Okayama. 2015;69(5):291-9.

48.

A Case of Sudden Infant Death Due to Incomplete Kawasaki Disease.

Yajima D, Shimizu K, Oka K, Asari M, Maseda C, Okuda K, Shiono H, Ohtani S, Ogawa K.

J Forensic Sci. 2016 Jan;61 Suppl 1:S259-64. doi: 10.1111/1556-4029.12929. Epub 2015 Sep 8.

PMID:
26347043
49.

The Trentepohliales (Ulvophyceae, Chlorophyta): An Unusual Algal Order and its Novel Plant Pathogen-Cephaleuros.

Brooks F, Rindi F, Suto Y, Ohtani S, Green M.

Plant Dis. 2015 Jun;99(6):740-753. doi: 10.1094/PDIS-01-15-0029-FE.

PMID:
30699526
50.

Effectiveness of therapeutic barium enema for diverticular hemorrhage.

Matsuura M, Inamori M, Nakajima A, Komiya Y, Inoh Y, Kawasima K, Naitoh M, Fujita Y, Eduka A, Kanazawa N, Uchiyama S, Tani R, Kawana K, Ohtani S, Nagase H.

World J Gastroenterol. 2015 May 14;21(18):5555-9. doi: 10.3748/wjg.v21.i18.5555.

Supplemental Content

Loading ...
Support Center